|
|
|
|
|
Topics
|
|
Glioblastoma
| Etiopathogenesis | Microenvironment | Immunosuppression
|
|
|
|
Home
> Publications
> Topics
> Glioblastoma
>
Etiopathogenesis
>
Microenvironment
>
Immunosuppression
|
|
|
|
|
2025
|
|
|
Nicolaou N, Andreou MS, Neophytou CM, Papageorgis P.
Emerging
insights into the immunosuppressive tumor microenvironment and its
implications for glioblastoma immunotherapy.
Front
Immunol. 2025 Oct 24;16:1665742. doi:
10.3389/fimmu.2025.1665742. PMID:
41208963. Review. ˍ
|
|
|
|
Wei Y, Shi Y, Wang H, Shang Y, Yu B, Zhang Y.
Glioblastoma
insights: Focus on crosstalk with the suppressive tumor
microenvironment and advanced therapeutic strategies.
Medicine
(Baltimore). 2025 Dec 5;104(49):e46285. doi:
10.1097/MD.0000000000046285. PMID:
41366964. Review. ˍ
|
|
|
|
Pang C, Wang Y.
The Immunosuppressive
Microenvironment of Glioblastoma: Mechanisms, Clinical Challenges
and Future Directions.
Immunology.
2025 Dec 19. doi:
10.1111/imm.70087. PMID:
41414954. Review. ˍ
|
|
|
|
|
2026
|
|
|
Figg
JW, Flores CT.
Rewriting
microenvironment immunity in glioblastoma.
Mol
Ther Oncol.
2026 Jun 9;34(2):201245. doi:
10.1016/j.omton.2026.201245. PMID:
42291139. ˍ
|
|
|
|
Yang J, Li J, Jin M, Lu Y, Zhang L.
The
immunosuppressive tumor microenvironment in glioblastoma.
Front
Immunol. 2026 Jul 2;17:1806996. doi:
10.3389/fimmu.2026.1806996. PMID:
42465775. ˍ
|
|
|
|
Omene E.
Metabolic cell competition in
the glioblastoma tumour microenvironment: glucose, glutamine, and
lactate as determinants of immune
exclusion and targets for pharmacological reprogramming.
Front
Oncol. 2026 Jul 14;16:1849888. doi:
10.3389/fonc.2026.1849888. PMID:
42523684. ˍ
|
|
|
|
Aydın HA, Keskin E, Kalaycı M.
Reprogramming
the immunosuppressive microenvironment in glioblastoma: the
microglia-MDSC-Treg axis and translational therapeutic strategies.
Front
Oncol. 2026 Aug 10;16:1782775. doi:
10.3389/fonc.2026.1782775. PMID:
42639384. ˍ
|
|
|
|
Souat S, El Azhary K, Bourdoukh S, Kone AS, Qandouci A, Harmak Z,
Choukri K, Lakhdar A, Badou A.
Elevated
BTLA Expression Correlates with an Immunosuppressive
Microenvironment and Defines Dysfunctional Circulating T Cells in
Human Glioblastoma.
Med
Sci (Basel). 2026 Jul 25;14(4):433. doi:
10.3390/medsci14040433. PMID:
42646567. ˍ
|
|
|
|
|
|
|
|
|
|
|
|
|